VI
ANIP icon

Vestcor Inc’s ANI Pharmaceuticals ANIP Stock Holding History

Vestcor Inc’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$192K Hold
2,325
– – ﹤0.01% 1046
2026
Q1 		$179K Hold
2,325
– – ﹤0.01% 1050
2025
Q4 		$184K Hold
2,325
– – 0.01% 970
2025
Q3 		$213K Buy
+2,325
New +$190K 0.01% 967

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vestcor Inc's ANIP Position: Q2 2026 in Review

Vestcor Inc held its ANI Pharmaceuticals (ANIP) position steady in Q2 2026 at 2,325 shares worth $192K. The position accounts for ﹤0.01% of the portfolio, ranked #1046.

Vestcor Inc first reported a position in ANIP in Q3 2025 and has held it in 4 quarters since. The position peaked at $213K in Q3 2025. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Vestcor Inc held 2,325 shares of ANI Pharmaceuticals worth $192K as of Q2 2026.
  • Vestcor Inc left its ANI Pharmaceuticals share count unchanged in Q2 2026.
  • ANI Pharmaceuticals made up ﹤0.01% of Vestcor Inc's portfolio in Q2 2026, its #1046 holding.
  • Vestcor Inc first reported a position in ANI Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • Vestcor Inc's ANI Pharmaceuticals position peaked at $213K in Q3 2025.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Vestcor Inc's 13F filing for Q2 2026, filed 11 Aug 2026.